Some treatment dilemmas in rapidly developing dementia: A case report

World Journal of Biological Psychiatry

Volumn 9, Issue 1, 2008, Pages 64-68

  Jakovljevic, Miro ^a   Vuksan Cusa, Bianka ^a   Topic, Radmila ^a  

^a KBC Zagreb   (Croatia)

Author keywords

Donepezil; Drug combination strategy; Memantine; Olanzapine; Rapidly developing dementia

Indexed keywords

DONEPEZIL; MEMANTINE; OLANZAPINE; OMEGA 3 FATTY ACID; VITAMIN B COMPLEX;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; DEMENTIA; DISEASE COURSE; DRUG DOSE TITRATION; EVENING DOSAGE; HOSPITAL ADMISSION; HUMAN; LEARNING DISORDER; MALE; MEMORY DISORDER; NEUROLOGIC EXAMINATION; SCORING SYSTEM; SPEECH DISORDER; UNSPECIFIED SIDE EFFECT;

AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHOLINESTERASE INHIBITORS; DEMENTIA; DEPRESSION; DISEASE PROGRESSION; DOPAMINE AGONISTS; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAPHY; HUMANS; INDANS; MALE; MEMANTINE; NEUROPSYCHOLOGICAL TESTS; PIPERIDINES; SEVERITY OF ILLNESS INDEX;

EID: 39149089297     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970701568370     Document Type: Article

References (27)

1. Alexopoulos, GS, Jeste, DV, Chung, H., Carpenter, D., Ross, R. and Docherty, JP (2005) The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Intdroduction: Methods, commentary, and summary. Postgrad Med, pp. 6-22.
2. Brett, AS (2005) Mortality associated with conventional vs. atypical antipsychotic drugs. Journal Watch, p. 1.
3. Burns, A., O'Brien, J. and on behalf of the BAP Dementia Consensus Group (2006) Clinical practice with anti-dementia drugs: A consensus statement from British Association for Psychopharmacology. J Psychopharmacol, 20, pp. 732-755.
4. Cummings, JL, McRae, T., Zhang, R. and The Donepezil-Sertraline Study Group (2006) Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders. Am J Geriatr Psychiatry, 14, pp. 605-612.
5. Drevets, WC and Rubin, RH. (1989) Psychotic symptoms and longitudinal course of senile dementia of the Alzheimer type. Biol Psychiatry, 25, pp. 39-48.
6. Evans, JG, Wilcock, G. and Birks, J. (2005) Evidence-based pharmacotherapy of Alzheimer's disease. Evidence-based psychopharmacology, pp. 290-319. Cambridge University Press, Cambridge
7. Herve, A. and Bentue-Ferrer, D. (2006) The anti-dementia drugs: Myth, hype or reality?. Clin Neuropharmacol, 29, pp. 10-14.
8. Fillit, HM, Doody, RS and Binaso, K. (2006) Recommendations for best practice in the treatment of Alzheimer's disease in managed care. Am J Geriatr Pharmacother, 4, p. s9.
9. Folstein, MF, Folstein, SE and McHugh (1975) Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 12, pp. 189-198.
10. Gauthier, S. (2005) Drugs for Alzheimer's disease and related dementias. Br Med J, 330, pp. 857-858.
11. Gauthier, S., Wirt, Y. and Moebius, HJ. (2005) Effects of memantine on behavioural symptoms in Alzheimer's disease patients: An analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies. Int J Geriatr Psychiatry, 20, pp. 459-464.
12. Jakovljevic, M. (2005) Modern psychopharmacotherapy and new concepts of treatment: From treatment nihilism to treatment renaissance and complete reintegration. Psychiatr Danubina, 17, pp. 243-245.
13. Kaufer, DI. (2004) A case study in the treatment of dementia with Lewy bodies. Acta Psychiatr Scand, 110, pp. 73-76.
14. Khotianov, N., Singh, R. and Singh, S. (2002) Lewy body dementia. vascular dementia. Case report and discussion. J Am Board Fam Pract, 15, pp. 50-54.
15. Kozman, MN, Wattis, J. and Curran, S. (2006) Pharmacological management of behavioural and psychological disturbance in dementia. Hum Psychopharmacol Clin Exp, 21, pp. 1-12.
16. McShane, R., Keene, J., Gedling, K., Fairburn, C., Jacoby, R. and Hope, T. (1997) Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up. Br Med J, 314, pp. 266-270.
17. Nasrallah, HA, White, T. and Nasrallah, AT. (2004) Lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol: Preliminary analysis of retrospective data. Am J Geriatr Psychiatry, 12, pp. 437-439.
18. Orgogozo, JM, Rigaud, AS, Stoeffler, A., Moebius, HJ and Forette, F. (2002) Efficacy and safety of memantine in patients with mild to moderate vascular dementia. Stroke, 33, pp. 1834-1839.
19. Reeves, RR and Torres, RA. (2003) Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia. South Med J, 96, pp. 699-701.
20. Schmitt, B., Bernhardt, T., Moeller, HJ, Heuser, I. and Froelich, L. (2004) Combination therapy in Alzheimer's disease: A review of current evidence. CNS Drugs, 18, pp. 827-844.
21. Schneider, LS, Dagerman, K. and Insel, PS. (2006) Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry, 14, pp. 191-210.
22. Sonkusare, SK, Kaul, CL and Ramarao, P. (2005) Dementia of Alzheimer's disease and other neurodegenerative disorders-memantine, a new hope. Pharmacol Res, 51, pp. 1-17.
23. Standridge, JB. (2004) Pharmacotherapeutic approaches to the treatment of Alzheimer's disease. Clin Ther, 26, pp. 615-630.
24. Tariot, PN, Farlow, MR, Grossberg, GT, Graham, SM, McDonald, S., Gergel, I. and for the Memantine Study Group (2004) Memantine treatment in patients with moderate to severe Alzheimer Disease already receiving donepezil. J Am Med Assoc, 291, pp. 317-524.
25. Tobiansky, B. and Blanchard, M. (1997) Trials must determine which neuroleptics are best in dementia (letter). Br Med J, 314, p. 1411.
26. Wang, PS, Schneeweiss, S. and Avorn, J. (2005) Risk of death in elderly users of conventional vs. atypical antipsychotic medications. New Engl J Med, 353, pp. 2335-2341.
27. Zarit, SH, Reever, KE and Bach-Peterson, J. (1980) Relatives of the impaired elderly: Correlates of feelings of burden. Gerontologist, 20, pp. 649-655.